These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 12871826)

  • 1. An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells.
    Kurikawa N; Suga M; Kuroda S; Yamada K; Ishikawa H
    Br J Pharmacol; 2003 Jul; 139(6):1085-94. PubMed ID: 12871826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of carbon tetrachloride-induced hepatic oxidative stress, injury and fibrosis by olmesartan and omega-3.
    Shaaban AA; Shaker ME; Zalata KR; El-kashef HA; Ibrahim TM
    Chem Biol Interact; 2014 Jan; 207():81-91. PubMed ID: 24144775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Connective tissue growth factor induction in a pressure-overloaded heart ameliorated by the angiotensin II type 1 receptor blocker olmesartan.
    Iwamoto M; Hirohata S; Ogawa H; Ohtsuki T; Shinohata R; Miyoshi T; Hatipoglu FO; Kusachi S; Yamamoto K; Ninomiya Y
    Hypertens Res; 2010 Dec; 33(12):1305-11. PubMed ID: 20944640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in rats.
    Ueki M; Koda M; Yamamoto S; Matsunaga Y; Murawaki Y
    J Gastroenterol; 2006 Oct; 41(10):996-1004. PubMed ID: 17096069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat.
    Lubel JS; Herath CB; Tchongue J; Grace J; Jia Z; Spencer K; Casley D; Crowley P; Sievert W; Burrell LM; Angus PW
    Clin Sci (Lond); 2009 Sep; 117(11):375-86. PubMed ID: 19371232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of angiotensin II and angiotensin II type 1 receptor antagonist on the proliferation, contraction and collagen synthesis in rat hepatic stellate cells.
    Liu J; Gong H; Zhang ZT; Wang Y
    Chin Med J (Engl); 2008 Jan; 121(2):161-5. PubMed ID: 18272044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effects.
    Kurita S; Takamura T; Ota T; Matsuzawa-Nagata N; Kita Y; Uno M; Nabemoto S; Ishikura K; Misu H; Ando H; Zen Y; Nakanuma Y; Kaneko S
    Eur J Pharmacol; 2008 Jul; 588(2-3):316-24. PubMed ID: 18501344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats.
    Bataller R; Gäbele E; Parsons CJ; Morris T; Yang L; Schoonhoven R; Brenner DA; Rippe RA
    Hepatology; 2005 May; 41(5):1046-55. PubMed ID: 15841463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis.
    Hirose A; Ono M; Saibara T; Nozaki Y; Masuda K; Yoshioka A; Takahashi M; Akisawa N; Iwasaki S; Oben JA; Onishi S
    Hepatology; 2007 Jun; 45(6):1375-81. PubMed ID: 17518368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of intrarenal angiotensin II levels in uninephrectomized aldosterone/salt-treated hypertensive rats; renoprotective effects of an ultrahigh dose of olmesartan.
    Fan YY; Baba R; Nagai Y; Miyatake A; Hosomi N; Kimura S; Sun GP; Kohno M; Fujita M; Abe Y; Nishiyama A
    Hypertens Res; 2006 Mar; 29(3):169-78. PubMed ID: 16755152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and experimental aspects of olmesartan medoxomil, a new angiotensin II receptor antagonist.
    Yoshida K; Kohzuki M
    Cardiovasc Drug Rev; 2004; 22(4):285-308. PubMed ID: 15592575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olmesartan medoxomil treatment potently improves cardiac myosin-induced dilated cardiomyopathy via the modulation of ACE-2 and ANG 1-7 mas receptor.
    Sukumaran V; Veeraveedu PT; Lakshmanan AP; Gurusamy N; Yamaguchi K; Ma M; Suzuki K; Kodama M; Watanabe K
    Free Radic Res; 2012 Jul; 46(7):850-60. PubMed ID: 22497476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive, insulin-sensitising and renoprotective effects of a novel, potent and long-acting angiotensin II type 1 receptor blocker, azilsartan medoxomil, in rat and dog models.
    Kusumoto K; Igata H; Ojima M; Tsuboi A; Imanishi M; Yamaguchi F; Sakamoto H; Kuroita T; Kawaguchi N; Nishigaki N; Nagaya H
    Eur J Pharmacol; 2011 Nov; 669(1-3):84-93. PubMed ID: 21816148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of olmesartan medoxomil as an angiotensin II-receptor blocker in chronic hypoxic rats.
    Nakamoto T; Harasawa H; Akimoto K; Hirata H; Kaneko H; Kaneko N; Sorimachi K
    Eur J Pharmacol; 2005 Dec; 528(1-3):43-51. PubMed ID: 16336959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonizing the angiotensin II subtype 1 receptor: a focus on olmesartan medoxomil.
    Nussberger J; Koike H
    Clin Ther; 2004; 26 Suppl A():A12-20. PubMed ID: 15291375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Swertiamarin Attenuates Experimental Rat Hepatic Fibrosis by Suppressing Angiotensin II-Angiotensin Type 1 Receptor-Extracellular Signal-Regulated Kinase Signaling.
    Li S; Wang Q; Tao Y; Liu C
    J Pharmacol Exp Ther; 2016 Nov; 359(2):247-255. PubMed ID: 27543328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetramethylpyrazine inhibits angiotensin II-induced activation of hepatic stellate cells associated with interference of platelet-derived growth factor β receptor pathways.
    Zhang X; Zhang F; Kong D; Wu X; Lian N; Chen L; Lu Y; Zheng S
    FEBS J; 2014 Jun; 281(12):2754-68. PubMed ID: 24725506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olmesartan Improves Hepatic Sinusoidal Remodeling in Mice with Carbon Tetrachloride-Induced Liver Fibrosis.
    Wu Y; Ge X; Wang SN; Zhang CQ
    Biomed Res Int; 2022; 2022():4710993. PubMed ID: 36060127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective activation of Toll-like receptor 7 in activated hepatic stellate cells may modulate their profibrogenic phenotype.
    Chou MH; Huang YH; Lin TM; Du YY; Tsai PC; Hsieh CS; Chuang JH
    Biochem J; 2012 Oct; 447(1):25-34. PubMed ID: 22765640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of the nuclear high mobility group B1 peptides released from injured hepatocytes in murine hepatic fibrogenesis.
    Kao YH; Lin YC; Tsai MS; Sun CK; Yuan SS; Chang CY; Jawan B; Lee PH
    Biochim Biophys Acta; 2014 Sep; 1842(9):1720-32. PubMed ID: 24970745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.